Vaccine Reaction: Clinical Trials

10 trials for Vaccine Reaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown, 2 not yet recruiting, 1 completed. 10 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Unknown 7, Not yet recruiting 2, Completed 1
Phase 24Unknown 2, Completed 1, Not yet recruiting 1

Follow Vaccine Reaction: new trials by email Literature Review of Vaccine Reaction trials Research Report on Vaccine Reaction

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant
PCV-LITE, PCV-LITE+LVA, PCV20 - Vaccine Reaction
Phase 1Not yet recruitingLiteVax BV802025-07-012025-05-22
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula A, DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula B, Registered DTwP-Hepatitis B-Hib Vaccine and IPV (Sinovac)® - Vaccine Adverse Reaction, Vaccine Reaction
Phase 1 / Phase 2Not yet recruitingPT Bio Farma4652025-03-012024-11-15
Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection
Venezuelan Equine Encephalitis DNA Vaccine, PharmaJet Stratis Needle-free Injection System, PharmaJet Tropis Needle-free Injection System - Vaccine Reaction
Phase 1UnknownPharmaJet, Inc.462023-10-162024-05-24
Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults
S.opt.FL COVID-19 pDNA vaccine - Safety, Vaccine Reaction
Phase 1UnknownIman Almansour302022-11-202022-10-19
Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer
Coronavirus vaccination - Patients With Cancer, Vaccine Reaction
Phase 1 / Phase 2UnknownBeijing 302 Hospital1002022-02-112022-04-18
UNAIR Inactivated COVID-19 Vaccine
UNAIR Inactivated COVID-19 Vaccine, CoronaVac Biofarma COVID-19 Vaccine - COVID-19 Pandemic, Vaccine Reaction
Phase 1 / Phase 2UnknownDr. Soetomo General Hospital4952022-02-082023-06-15
Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)
Covi Vax - COVID-19, Vaccine Reaction
Phase 1UnknownNational Research Centre, Egypt722021-11-142021-11-22
A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults
FMP013, ALFQ - Vaccine Reaction
Phase 1UnknownU.S. Army Medical Research and Development Command462020-03-202023-01-10
A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults
FMP014, ALFQ - Vaccine Reaction
Phase 1UnknownU.S. Army Medical Research and Development Command462020-03-202021-04-19
A Bridging Study of the SYN023 on Healthy Adult Subjects
recombinant anti-rabies human monoclonal antibody injection (SYN023), Rabies Vaccine - Communicable Disease Transmission, Zoonotic Disease
Phase 1 / Phase 2CompletedSynermore Biologics (Suzhou) Co., Ltd.332019-02-262021-09-29

Narrower conditions

COVID-19 (4)  ·  Infections (1)  ·  Malaria, Falciparum (1)  ·  Zoonoses (1)

Broader conditions

Infections (5)  ·  Coronaviridae Infections (4)  ·  Coronavirus Infections (4)  ·  Lung Diseases (4)  ·  Nidovirales Infections (4)  ·  Pneumonia (4)  ·  Pneumonia, Viral (4)  ·  RNA Virus Infections (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Infections (4)  ·  Virus Diseases (4)  ·  Animal Diseases (1)  ·  Malaria (1)  ·  Mosquito-Borne Diseases (1)  ·  Parasitic Diseases (1)

Interventions

NRC-VACC-101 vaccine (1)  ·  Poliovirus Vaccine, Inactivated (1)  ·  Rabies Vaccines (1)

Sponsors

U.S. Army Medical Research and Development Command (2)  ·  Beijing 302 Hospital (1)  ·  Dr. Soetomo General Hospital (1)  ·  Iman Almansour (1)  ·  LiteVax BV (1)  ·  National Research Centre, Egypt (1)  ·  PT Bio Farma (1)  ·  PharmaJet, Inc. (1)  ·  Synermore Biologics (Suzhou) Co., Ltd. (1)

Countries

United States (3)  ·  China (2)  ·  Indonesia (2)  ·  Egypt (1)

Top investigators

Dominicus Husada, MD (1)  ·  Osama Azmy, MD (1)  ·  Shu-juan Li, MD (1)

Results publications

PMID 29261658, PMID 33091433, PMID 36055874